Tonix Pharma (TNXP) Tops Q1 EPS by 284c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of $2.84. Revenue for the quarter came in at $2.43 million versus the consensus estimate of $4.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Laser Photonics CEO takes leave, EVP named interim president